secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001193125-25-203746
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix effects 1-for-20 reverse stock split, eliminates Series A preferred
----------------------------------------------------------------------------

- Reverse stock split at 1:20 ratio effective Sep 15, 2025; new CUSIP 09075X207.
- No fractional shares issued; cash-in-lieu based on closing price before effective date.
- Certificate of Elimination for Series A Non-Voting Convertible Preferred filed Sep 12, 2025.
- Stockholder approval obtained May 20, 2025; Board set final ratio on Sep 4, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312525203746/0001193125-25-203746-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312525203746/d14130d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-203746

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer